Sonoma Pharmaceuticals (SNOA) Receivables - Other (2012 - 2016)

Sonoma Pharmaceuticals' Receivables - Other history runs 5 years deep, the most recent figure standing at $912000.0 for Q1 2016.

• In Q1 2016, Receivables - Other rose 8.19% year-over-year to $912000.0; the TTM figure through Mar 2016 stood at $912000.0 (up 8.19% YoY), while the FY2016 annual figure was $912000.0, up 8.19% from the prior year.
• Receivables - Other was $912000.0 for Q1 2016 at Sonoma Pharmaceuticals, up from $843000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $912000.0 in Q1 2016 to a low of $264000.0 in Q1 2013.
• Historically, Receivables - Other has averaged $533142.9 across 5 years, with a median of $439000.0 in 2012.
• The sharpest annual moves came in 2013 and 2014: Receivables - Other dropped 8.97% in 2013, then surged 130.68% in 2014.
• A 5-year view of Receivables - Other shows it stood at $439000.0 in 2012, then slumped by 39.86% to $264000.0 in 2013, then surged by 130.68% to $609000.0 in 2014, then jumped by 38.42% to $843000.0 in 2015, then grew by 8.19% to $912000.0 in 2016.
• The last three Receivables - Other figures came in at $912000.0 (Q1 2016), $843000.0 (Q1 2015), and $609000.0 (Q1 2014), per Business Quant data.